Author

A. Shinkai

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1

Frequent Co-Authors

B. J. F. Keijser· 1 shared C. D. Schoen· 1 shared D. W. Taylor· 1 shared J. A. Steens· 1 shared J. P. K. Bravo· 1 shared J. van der Oost· 1 shared L. M. Hofstra· 1 shared M. Ossendrijver· 1 shared

Activity by Year

2021-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBiochemistry

B. J. F. Keijser

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

SCOPE: Flexible targeting and stringent CARF activation enables type III CRISPR-Cas diagnostics

J. A. Steens, Y. Zhu, D. W. Taylor, J. P. K. Bravo, S. H. P. Prinsen, C. D. Schoen, B. J. F. Keijser, M. Ossendrijver, L. M. Hofstra, S. J. J. Brouns, A. Shinkai, J. van der Oost, R. H. J. Staals

This study identifies key regions in type III CRISPR-Cas systems for RNA targeting and cOA production, leading to the development of the SCOPE diagnostic tool for SARS-CoV-2 detection.

Nature Communications · Aug 19, 2021Peer-reviewedBiochemistry